Biblio
AKT inhibitor AZD5363 suppresses stemness and promotes anti-cancer activity of 3,3'-diindolylmethane in human breast cancer cells. Toxicol Appl Pharmacol. 2021:115700.
. .
Efficacy and Safety of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Diabetic Retinopathy. Cell Physiol Biochem. 2018;49(1):40-52.
.
.
Reprogramming neurons for regeneration: the fountain of youth. Prog Neurobiol. 2022:102284.
. Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell-derived spheres. Naunyn Schmiedebergs Arch Pharmacol. 2023.
.